Michael D. Dale
Senior Vice President, Abbott Laboratories.
Companies
- CVRx (United States)Board member Jun 3, 2026 to now1
- Axogen, Inc.Chief executive officer Aug 9, 2024 to now2
- Axogen, Inc.Board member Aug 9, 2024 to Aug 9, 20242
- Axogen, Inc.President Aug 9, 2024 to Aug 9, 20242
- Abbott LaboratoriesSenior Vice President Nov 19, 2019 to Mar 2, 20233
- GI Dynamics (United States)Board member Sep 19, 2014 to Sep 21, 20154
- GI Dynamics (United States)Chief executive officer Sep 19, 2014 to Sep 21, 20154
- GI Dynamics (United States)President Sep 19, 2014 to Sep 21, 20154
- ATS MedicalChief executive officer Jan 12, 2006 to Aug 12, 20105
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Abbott Laboratories ABT45,133 shares6$4.7M at $104.71Mar 1, 2023- Axogen, Inc. AXGN63,537 shares7$2.2M at $34.55Dec 10, 2025
- CVRx (United States) CVRX29,005 shares8$37.6K at $1.29Jun 1, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 1, 2026Granted 29,005 shares of CVRx (United States)8
- Dec 10, 2025Sold 25,000 shares at $30.00 of Axogen, Inc.7
- Dec 9, 2025Sold 61,463 shares at $31.21 of Axogen, Inc.9
- Dec 4, 2025Granted 150,000 shares of Axogen, Inc.10
- Mar 1, 2023Sold 1,209 shares at $100.70 of Abbott Laboratories6
- Feb 28, 2023Shares withheld for tax 4,942 shares at $99.77 of Abbott Laboratories6
- Feb 17, 2023Granted 9,504 shares of Abbott Laboratories11
- Mar 8, 2022Sold 4,000 shares at $117.00 of Abbott Laboratories12
- Mar 1, 2022Sold 1,053 shares at $118.15 of Abbott Laboratories13
- Feb 28, 2022Shares withheld for tax 4,505 shares at $122.41 of Abbott Laboratories13
- Feb 18, 2022Granted 11,647 shares of Abbott Laboratories14
- Jul 28, 2021Sold 17,600 shares at $120.33 of Abbott Laboratories15
- Jul 28, 2021Exercised options 17,600 shares at $50.72 of Abbott Laboratories15
- Mar 1, 2021Sold 1,475 shares at $120.61 of Abbott Laboratories16
- Feb 26, 2021Shares withheld for tax 4,000 shares at $121.58 of Abbott Laboratories16
- Feb 19, 2021Granted 10,403 shares of Abbott Laboratories17
- Mar 2, 2020Sold 787 shares at $77.89 of Abbott Laboratories18
- Feb 28, 2020Shares withheld for tax 2,147 shares at $79.19 of Abbott Laboratories18
- Feb 21, 2020Granted 13,750 shares of Abbott Laboratories19
- Feb 19, 2020Sold 396 shares at $88.97 of Abbott Laboratories20
- Feb 17, 2020Shares withheld for tax 951 shares at $89.66 of Abbott Laboratories20
Trade performance
| Date | Stock | Trade | Value | Return since | Vs S&P since | Vs S&P, 1 year |
|---|---|---|---|---|---|---|
| Mar 1, 2023 | ABT | Sale | $121.7K | +4.0% | +91.5% | +11.0% |
| Mar 8, 2022 | ABT | Sale | $468.0K | −9.7% | +95.1% | +10.2% |
| Mar 1, 2022 | ABT | Sale | $124.4K | −11.2% | +90.7% | +6.5% |
| Jul 28, 2021 | ABT | Sale | $2.1M | −13.0% | +88.8% | +1.0% |
| Mar 1, 2021 | ABT | Sale | $177.9K | −14.2% | +112.3% | +13.7% |
| Mar 2, 2020 | ABT | Sale | $61.3K | +28.5% | +121.2% | −25.1% |
| Feb 19, 2020 | ABT | Sale | $35.2K | +17.4% | +110.7% | −24.9% |
Returns are price-only (no dividends), measured from the trade date.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARCVRx (United States), Board member
- 2
- 3
- 4
- 5SEC EDGARATS Medical, Chief executive officer
- 6
- 7
- 8
- 9SEC EDGARForm 4 filed Dec 10, 2025
- 10SEC EDGARForm 4 filed Dec 5, 2025
- 11SEC EDGARForm 4 filed Feb 22, 2023
- 12SEC EDGARForm 4 filed Mar 10, 2022
- 13SEC EDGARForm 4 filed Mar 2, 2022
- 14SEC EDGARForm 4 filed Feb 23, 2022
- 15SEC EDGARForm 4 filed Jul 30, 2021
- 16SEC EDGARForm 4 filed Mar 2, 2021
- 17SEC EDGARForm 4 filed Feb 23, 2021
- 18SEC EDGARForm 4 filed Mar 3, 2020
- 19SEC EDGARForm 4 filed Feb 25, 2020
- 20SEC EDGARForm 4 filed Feb 19, 2020